Futuximab
Product Specifications
CAS Number
1310460-85-5
Target
EGFR
Related Pathways
JAK/STAT signaling|||Angiogenesis|||Tyrosine Kinase/Adaptors
Purity
0.975
Bioactivity
Futuximab is a chimeric monoclonal antibody targeting EGFR, commonly used in combination with zatuximab to form Sym004. Sym004 targets non-overlapping epitopes on EGFR, exhibiting antitumour activity.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
A2275-85P-HRP 200 µL
APP, NT (Amyloid beta A4 Protein, APP, ABPP, Alzheimer Disease Amyloid Protein, Cerebral Vascular Amyloid Peptide, CVAP, Protease Nexin-II, PN-II, APPI, PreA4, A4, AD1) (Azide free) (HRP) discontinued
Ask
View Details 
MBS1176461-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Cell wall protein DAN1 (DAN1)
Ask
View Details MBS1176461-02 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Cell wall protein DAN1 (DAN1)
Ask
View Details